Halo Labs Reports Record Q1 2019 Revenue of US $8.7MM: US Cannabis Extraction Specialist Revenue up ~190% from Q4 2018
Ryan Allway May 10th, 2019 App, News, Top News Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced its financial and operational results for the first quarter ended March 31, 2019. Entry into the California market fueled significant growth as revenues these three months... Read more
FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media
Ryan Allway May 10th, 2019 App, Exclusive, News, Top Story FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) is a licensed producer focused on building out a 3.9 million sq. ft. indoor hydroponic facility near Toronto capable of producing 400,000 kilograms of dried cannabis per year. With a newly acquired... Read more

Read more

Read more

Read more
Pascal Biosciences Announces Formation of Clinical Advisory Board
VANCOUVER, British Columbia and SEATTLE, May 08, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS)(“Pascal” or the “Company”), a drug discovery and development company, today announced it has formed a clinical advisory board (“CAB”) of preeminent neuro-oncology experts to guide its PAS-403 therapeutic program. PAS-403 is Pascal’s clinical candidate for... Read more

Read more

Canopy Growth Introduces Spectrum Therapeutics

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) introduces Spectrum Therapeutics, a new global brand that will encompass all of the Company’s ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and Bionorica SE-founded C3Cannabinoid Compound Company.

Read more

Read more

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )